Push2Spin Technologies
Overview
Push2Spin Technologies, founded in 2021 by Jeff and Beth Gusenoff, is an innovative startup focused on developing disruptive technologies in the field of soft tissue grafting. Headquartered in Pittsburgh, Pennsylvania, this private company has so far raised over $400,000 to fund its pioneering work. Push2Spin aims to revolutionize small-volume fat tissue harvesting, processing, and transfer, enhancing the efficiency and effectiveness of existing medical processes. The company has garnered attention for its novel approach and contributions to the surgical devices industry.
Recent Developments
- February 2024: Push2Spin Technologies secured debt financing amounting to $10,000, continuing its journey of innovation in medical device technology.
- 2023: Push2Spin was actively involved in the medical technology community, promoting its solutions at various conferences and on platforms like LinkedIn. The company gained significant attention for its cutting-edge fat transfer device designed to transform procedures in plastic surgery and other specialties.
- July 2023: According to Innovation Works, Push2Spin was recognized as a key player in the soft tissue grafting market, allowing rapid fat preparation for reinjection post-liposuction.
- November 2022: Push2Spin continued to refine its push-inject technology, receiving accolades for its simplicity and reduced procedure times, which enhance both surgeon efficiency and patient experience.
Company Information
| Attribute | Information |
|---|---|
| Founding Date | 2021 |
| Headquarters | Pittsburgh, PA |
| Founders | Jeff and Beth Gusenoff |
| Revenue | Not Publicly Available |
| Profits | Not Publicly Available |
| Key Investors | LifeX Ventures, Innovation Works, ASPS Innovation & Entrepreneurship Hub |
| Industry | Surgical Devices |
| Number of Employees | 2 |
Early History
Jeff and Beth Gusenoff, both clinicians with expertise in plastic and podiatric surgeries, laid the foundation for Push2Spin Technologies in 2021. Their journey began with their innovative research at the University of Pittsburgh, focusing on solutions for foot conditions and advancing fat grafting technologies. Their initial invention, PopSole, aimed at providing pressure relief in foot surgeries, received early-stage funding and helped pave the way for further innovation. The couple’s entrepreneurial spirit led to the conceptualization and creation of Push2Spin, with an objective to streamline the fat grafting process, leveraging inspiration from simple household devices such as salad spinners for medical purposes.
Company Profile and Achievements
Push2Spin Technologies has positioned itself as a forward-thinking company in the medical device industry, particularly focusing on fat grafting solutions. Its core business model revolves around the development and commercialization of technologies that simplify and accelerate the preparation and reinjection of fat tissue. This focus not only improves procedural efficiency but also significantly reduces operation times, a factor that makes the technology particularly appealing to medical practitioners.
- 2021: Foundation of Push2Spin Technologies, Inc. with strategic alliances to support innovation and commercialization.
- 2022: The launch of its signature device which minimizes procedure time to about 30 minutes from the traditional two hours.
- 2022 - 2023: Active participation in clinical trials to validate device efficiency and secure regulatory approval.
- Collaborations: Worked closely with the Adipose Stem Cell Laboratory at the University of Pittsburgh for testing and validation of their innovations.
Current Operations and Market Position
Currently, Push2Spin Technologies engages in the commercial deployment and further refinement of its innovative devices. As a small, agile company, it has carved a niche within the surgical devices market by offering unique solutions that streamline fat grafting procedures. The company's market position is bolstered by its alliances with key investors and partners, ensuring continued innovation and introduction of user-friendly medical devices. Push2Spin’s competitive advantage lies in its cutting-edge technology, which offers substantial time savings and process efficiency, enhancing patient care and procedural outcomes.
Conclusion
Push2Spin Technologies stands at the forefront of innovation in the field of surgical devices. With its novel solutions for fat tissue processing, Push2Spin promises to significantly impact the medical industry by reducing procedural complexities and enhancing cost-efficiency. As the company continues to expand and validate its technological advancements, it is well-positioned to influence global practices in fat grafting, projecting a potential shift in standard healthcare methodologies in the upcoming years. Although in its nascent stages, Push2Spin's focused leadership and strategic advancements suggest a promising trajectory in the medical device landscape.